4
Changes in Ownership
Emergent BioSolutions Inc. Filed Acc 0001685720-26-000003
Director sold 17,202 shares at an average $8.40 ($144,453)
- Director acquired 25,344 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Zoon Kathryn C · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-04-30 | Grant or award : show line 1 in the form 10b5-1 | +25,344 | 97,143 | D | ||
| 2026-05-01 | Sale : show line 2 in the form 10b5-1 | −16,145 | $8.36 | $134,972 | 80,998 | D |
| 2026-05-01 | Sale : show line 3 in the form 10b5-1 | −1,057 | $8.97 | $9,481 | 79,941 | D |
| Open-market sales · 17,202 sh · avg $8.40 · $144,453 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-04-30 | Grant or award : show line 4 in the form 10b5-1 Stock Option (Right to Buy) | +11,296 | 11,296 | D |
Loading xslF345X06/wk-form4_1777930077.xml…